BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Dec 05, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Intermezzo zolpidem regulatory update

FDA approved an NDA from Transcept for Intermezzo zolpidem to treat insomnia when a middle of the night awakening is followed by difficulty returning to sleep. The label states that Intermezzo is not indicated when...

Read the full 154 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >